Evidence map›Paper›PMID 30544611›Full record

ArticleInternational journal of molecular sciences2018

Effects of Reduced Graphene Oxides on Apoptosis and Cell Cycle of Glioblastoma Multiforme.

Jaroslaw Szczepaniak, Barbara Strojny, Ewa Sawosz Chwalibog, Slawomir Jaworski, Joanna Jagiello, Magdalena Winkowska, Maciej Szmidt, Mateusz Wierzbicki, Malwina Sosnowska, Jasmina Balaban and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Effect ofPeerJ · 2021
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Jaroslaw SzczepaniakDepartment of Animal Nutrition and Biotechnology, Faculty of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland. jaroslaw_szczepaniak@sggw.pl.ORCID 0000-0001-5808-9755
Barbara StrojnyDepartment of Animal Nutrition and Biotechnology, Faculty of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland. barbara_strojny@sggw.pl.ORCID 0000-0002-2642-5491
Ewa Sawosz ChwalibogDepartment of Animal Nutrition and Biotechnology, Faculty of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland. ewa_sawosz@sggw.pl.
Slawomir JaworskiDepartment of Animal Nutrition and Biotechnology, Faculty of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland. slawomir_jaworski@sggw.pl.
Joanna JagielloDepartment of Chemical Synthesis and Flake Graphene, Institute of Electronic Materials Technology, 01-919 Warsaw, Poland. joanna_jagiello@itme.edu.pl.
Magdalena WinkowskaDepartment of Chemical Synthesis and Flake Graphene, Institute of Electronic Materials Technology, 01-919 Warsaw, Poland. magdalena.winkowska@itme.edu.pl.
Maciej SzmidtDepartment of Morphologic Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland. Maciej.Szmidt@Acurian.com.
Mateusz WierzbickiDepartment of Animal Nutrition and Biotechnology, Faculty of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland. mateusz_wierzbicki@sggw.pl.
Malwina SosnowskaDepartment of Animal Nutrition and Biotechnology, Faculty of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland. malwina_sosnowska@sggw.pl.
Jasmina BalabanDepartment of Animal Nutrition and Biotechnology, Faculty of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland. jasmina_balaban@sggw.pl.
Anna WinnickaDepartment of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland. anna_winnicka@sggw.pl.ORCID 0000-0001-9918-3430
Ludwika LipinskaDepartment of Chemical Synthesis and Flake Graphene, Institute of Electronic Materials Technology, 01-919 Warsaw, Poland. ludwika_lipinska@itme.edu.pl.
Olga Witkowska PilaszewiczDepartment of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland. olga_witkowska_pilaszewicz@sggw.pl.
Marta GrodzikDepartment of Animal Nutrition and Biotechnology, Faculty of Animal Sciences, Warsaw University of Life Sciences, 02-787 Warsaw, Poland. marta_grodzik@sggw.pl.ORCID 0000-0001-5359-1885
Warsaw University of Life Sciences · PLInstitute of Electronic Materials Technology · PL

Funding

Narodowe Centrum Badań i Rozwoju LIDER/144/L-6/14/NCBR/2015
6 · The paper itself

Abstract

Graphene (GN) and its derivatives (rGOs) show anticancer properties in glioblastoma multiforme (GBM) cells in vitro and in tumors in vivo. We compared the anti-tumor effects of rGOs with different oxygen contents with those of GN, and determined the characteristics of rGOs useful in anti-glioblastoma therapy using the U87 glioblastoma line. GN/ExF, rGO/Term, rGO/ATS, and rGO/TUD were structurally analysed via transmission electron microscopy, Raman spectroscopy, FTIR, and AFM. Zeta potential, oxygen content, and electrical resistance were determined. We analyzed the viability, metabolic activity, apoptosis, mitochondrial membrane potential, and cell cycle. Caspase- and mitochondrial-dependent apoptotic pathways were investigated by analyzing gene expression. rGO/TUD induced the greatest decrease in the metabolic activity of U87 cells. rGO/Term induced the highest level of apoptosis compared with that induced by GN/ExF. rGO/ATS induced a greater decrease in mitochondrial membrane potential than GN/ExF. No significant changes were observed in the cytometric study of the cell cycle. The effectiveness of these graphene derivatives was related to the presence of oxygen-containing functional groups and electron clouds. Their cytotoxicity mechanism may involve electron clouds, which are smaller in rGOs, decreasing their cytotoxic effect. Overall, cytotoxic activity involved depolarization of the mitochondrial membrane potential and the induction of apoptosis in U87 glioblastoma cells.

Indexed as

Antineoplastic AgentsApoptosisCell CycleCell Line, TumorGlioblastomaGraphiteHumansMembrane Potential, MitochondrialOxidesReactive Oxygen SpeciesAntineoplastic AgentsGraphiteOxidesReactive Oxygen Speciesapoptosisbrain tumorcell cycleglioblastoma multiformeJC-1reduced graphene oxide

Identifiers

PMID30544611
PMCPMC6320889
OpenAlexW2904957357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.